While research studies have focused on understanding the roles of aberrant DNA methylation events in driving breast carcinogenesis, as prognostic tools and as tools to distinguish breast cancer subtypes, both levels, and alternate isoforms of TET1 have come to shed light on the mechanism of hypomethylation in one of the most hypomethylated tumor types. The gene discussed is TET1; the disease is breast carcinoma.